Cas:541547-37-9 Ethyl 2,2-Difluoro-3-Amino-Propanoate Hydrochloride manufacturer & supplier

We serve Chemical Name:Ethyl 2,2-Difluoro-3-Amino-Propanoate Hydrochloride CAS:541547-37-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl 2,2-Difluoro-3-Amino-Propanoate Hydrochloride

Chemical Name:Ethyl 2,2-Difluoro-3-Amino-Propanoate Hydrochloride
CAS.NO:541547-37-9
Synonyms:Ethyl 2,2-difluoro-3-aminopropanoate hydrochloride;ethyl 3-amino-2,2-difluoropropanoate,hydrochloride
Molecular Formula:C5H10ClF2NO2
Molecular Weight:189.58800
HS Code:2922499990

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:52.32000
Exact Mass:189.03700
LogP:1.64580

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Ethyl 2,2-difluoro-3-aminopropanoate hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 3-amino-2,2-difluoropropanoate,hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 2,2-difluoro-3-aminopropanoate hydrochloride Use and application,ethyl 3-amino-2,2-difluoropropanoate,hydrochloride technical grade,usp/ep/jp grade.


Related News: Immunocompromised people account for roughly 2.7% of U.S. adults including patients who’ve received an organ transplant, living with HIV or have received active or recent treatment for cancer, Oliver said. 2-amino-1,3-benzothiazole-6-carboxylic acid,hydrochloride manufacturers Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. 2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]-2-oxopyridin-1-yl]acetic acid suppliers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. 2-amino-6-nitrobenzo[de]isoquinoline-1,3-dione vendor & factory.